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Summary
What is already known?
 ► Decision support systems have significant poten-
tial in improving the safety, quality and efficiency 
of care. However, empirical work has indicated that 
implementation can introduce new errors and have 
unintended consequences. Careful evaluation of the 
introduction of such technologies and their impact is 
therefore needed.
What does this paper add?
 ► Our formative qualitative evaluation of a Scottish na-
tional programme to build a pilot Decision Support 
Platform indicated a strong sense of support from 
all stakeholders. However, in order to address po-
tential tensions between national leadership and 
local usability as well as potential unintended con-
sequences, there is a need to have overall nation-
al ownership to support the implementation of the 
Platform.
 ► Potential local tensions could be addressed through 
allowing a degree of local customisation of systems 
and tailoring of alerts and investing in a limited num-
ber of pilots that are carefully evaluated to mitigate 
emerging risks before the Platform is rolled out 
nationally.
AbStrACt
Context The Scottish Government has identified 
computerised decision support as a strategic priority in 
order to improve knowledge management in health and 
social care settings. A national programme to build a pilot 
Decision Support Platform was funded in 2015.
Aims We undertook a formative evaluation of the Decision 
Support Platform to inform plans for its national roll-out in 
primary care.
Methods We conducted a series of in-depth 
semistructured interviews and non-participant 
observations of workshops demonstrating decision 
support systems. Participants were policymakers and 
clinical opinion leaders from primary care. As the Platform 
was in its early stages of development at the time of 
data collection, we focused on exploring expectations 
and drivers of the pilot decision support system tested 
in primary care. Our methodological approach had to 
be tailored to changing circumstances and offered 
important opportunities for realising impact through 
ongoing formative feedback to policymakers and active 
engagement of key clinical stakeholders. We drew on 
sociotechnical principles to inform data analysis and coded 
qualitative data with the help of NVivo software.
Findings We conducted 30 interviews and non-
participant ethnographic observations of eight 
stakeholder engagement workshops. We observed a 
strong sense of support from all stakeholders for the 
Platform and associated plans to roll it out across NHS 
Scotland. Strategic drivers included the potential to 
facilitate integration of care, preventive care, patient 
self-management, shared decision-making and patient 
engagement through the ready availability of clinically 
important information. However, in order to realise these 
benefits, participants highlighted the need for strong 
national eHealth leadership to drive a coherent strategy 
and ensure sustained funding, system usability (which 
stakeholders perceived to be negatively affected by 
alert fatigue and integration with existing systems) and 
ongoing monitoring of potential unintended consequences 
emerging from implementations (eg, increasing clinical 
workloads).
Conclusions and implications In order to address 
potential tensions between national leadership and local 
usability as well as unintended consequences, there is a 
need to have overall national ownership to support the 
implementation of the Platform. Potential local tensions 
could be addressed through allowing a degree of local 
customisation of systems and tailoring of alerts, and 
investing in a limited number of pilots that are carefully 
evaluated to mitigate emerging risks early.
IntroduCtIon
In Scotland, there is a national strategic drive 
towards participatory, personalised, predic-
tive and preventive medicine.1 Decision 
support systems (DSS) are key enablers in the 
delivery of such a vision. They are character-
ised as information systems that draw on an 
active knowledge base to support the deci-
sion-making of its user, and can be used glob-
ally by health and social care professionals 
as well as by citizens who have an interest 
in tracking and quantifying their health 
and activities (eg, in diaries, appointment 
reminders, wearables).2
Electronic health record (EHR) infrastruc-
tures and the drive to integrate additional 
 o
n
 6 June 2019 by guest. Protected by copyright.
https://inform
atics.bmj.com/
BM
J Health Care Inform
: first published as 10.1136/bmjhci-2019-100022 on 2 June 2019. Downloaded from 
2 Cresswell K, et al. BMJ Health Care Inform 2019;26:e100022. doi:10.1136/bmjhci-2019-100022
Open access 
box 1 Summary of the Scottish national decision Support 
Programme
The Roadmap to deliver the Programme was published in June 2015. It 
set out three key milestones:
 ► Phase 1—18 months: Deliver clinical decision support (CDS) for 
antibiotic prescribing venous thromboembolism guidelines, pilot a 
Decision Support Web Gateway, define requirements for the knowl-
edge base and CDS Platforms.
 ► Phase 2—year 3: Deliver a Mobile Decision Support Toolbox, imple-
ment CDS for long-term conditions in primary care.
 ► Phase 3—year 5: Deliver a suite of point of care mobile CDS, im-
plement CDS with community systems, clinical portal and specialist 
systems.
Stakeholders: The implementation of the Roadmap was led by the 
Scottish Government and the Digital Health and Care Institute.
Objectives: By 2020, it was envisaged that CDS would be available to 
clinicians when needed on desktop computers and mobile applica-
tions. Although the Roadmap focused on CDS, there is a wider drive in 
Scotland to promote decision support systems (DSS) more generally, 
including citizen-facing functions.
Project organisation: It was envisaged that the Roadmap would be deliv-
ered by support roles including product management, knowledge man-
agement, technology design and delivery, and implementation support.
System architecture: The Roadmap proposed two key elements:
 ► Small-scale demonstrators: to show that benefit can be delivered 
and to build clinical engagement and leadership.
 ► The broader infrastructure including: a web place for users to access 
quality-assured web-based CDS and mobile apps, knowledge-based 
feeding algorithms, technology and content management tools, in-
cluding but not exclusively focused on prescribing, including alerts 
and reminders.
Progress at time of writing: Built digital infrastructure for national de-
livery of CDS. Some successful early adopter projects use these tools.
box 2 description of the pilot decision support system 
(dSS) Platform for the Scottish national decision Support 
Programme
 ► One part of the system architecture of the Scottish National Decision 
Support Programme.
 ► Engine that enables writing of clinical decision support algorithms.
 ► Can be plugged into any electronic health record (EHR) system and 
integrates patient-specific information with published guidelines 
and regulations.
 ► Includes development tools for portable apps.
 ► Built for open standard interfaces.
 ► Cloud based (in the developer’s own cloud that uses application 
programming interfaces to allow third-party vendors to link their 
applications to the Platform).
data streams, ranging from administrative, social care, 
genetic and patient-generated wearable data, harbour 
the potential for a major step-change across the Scottish 
health and social care (henceforth care) landscapes. In 
order to capitalise on these, the Scottish Government 
launched the national Decision Support Programme 
for NHS Scotland in 2015, which sought to develop an 
evidence-based strategy and associated delivery frame-
work for DSS.3
Clinical decision support (CDS) systems are a type of 
DSS that draw on real-time patient-specific information 
to generate individualised advice such as alerts (such 
as warnings and reminders) for clinicians tailored to 
the case at hand. They can be independent (apps or 
websites), interfaced (eg, to patient management systems 
or portals) or integrated (with EHRs). CDS to support 
prescribing is a key strategic priority area throughout 
much of the world including Scotland, as consistent 
empirical evidence points to a large proportion of poten-
tially avoidable morbidity and mortality caused by medi-
cation-related harm.4–6
Although it is now commonly recognised that CDS 
systems can improve practitioner performance and also 
reduce some medication error rates,7 8 there are concerns 
that CDS implementation can introduce new errors and 
have unintended consequences.9–13 For example, Ash and 
colleagues have described how CDS content and presen-
tation can lead to users ignoring potentially important 
alerts and promote errors (eg, through autocomplete 
functions).14 This illustrates a need for careful evalua-
tion of the introduction of such technologies and their 
impact.15
We were commissioned to conduct a formative evalu-
ation of the pilot DSS Platform for the Scottish National 
Decision Support Programme (see boxes 1 and 2), which 
combines an open standard-based algorithms editor and 
engine combined with bespoke decision support appli-
cations delivered as web and mobile products and inte-
grated into primary care EHR systems. We designed our 
formative work to help inform the ongoing development 
of the Programme through identifying early drivers and 
implementation strategies, anticipated challenges, and 
identifying potential ways to address these.16
MethodS
ethical approval
We obtained Institutional Review Board approval for the 
study from the Centre for Population Health Sciences 
at The University of Edinburgh, UK. We anonymised all 
places, names and organisations to ensure confidenti-
ality. Individual participants provided written informed 
consent for participation.
design
We conducted a formative qualitative evaluation consisting 
of a combination of face-to-face/telephone interviews 
and observations of workshops with representatives 
of different stakeholder groups including policy and 
strategy leads, system vendors and clinical opinion leaders 
(primarily general practitioners (GP) and pharmacists).
Sampling
Sampling was facilitated by the Scottish Government who 
helped to establish contacts with key stakeholder groups. 
We used purposeful sampling to select stakeholders that 
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were involved in planning, commissioning, development 
and early testing/use of the Platform.17 We attempted to 
ensure maximum variation in terms of background (clin-
ical, managerial, strategic) and geographical location.
We used a degree of respondent-driven sampling to 
maximise the chances of recruiting a maximum variation 
sample.18 In doing so, we selected clinical interviewees 
randomly from those attending the workshop to ensure a 
range of locations and professions.
data collection
We used semistructured interviews as the main method 
of data collection. We also undertook non-participant 
observation of workshops where the Platform and appli-
cations were demonstrated to clinical leads to observe 
the dynamics of prospective user reactions in situ. These 
workshops were led and facilitated by a representative 
from Scottish Government in order to engage key clinical 
opinion leaders. Participants were presented with demon-
strator scenarios showing how the Platform worked with 
the patient record, followed by interactive discussion of 
first impressions, expectations, drivers and potential chal-
lenges. Combining different methods enabled us to trian-
gulate the data sources to validate emerging findings.19
The interviews consisted of open-ended questions 
about the experiences of existing solutions and expected 
outputs of a Scotland-wide system through exploring:
 ► Stakeholders’ attitudes.
 ► Implementation strategies.
 ► Measurements for the impact of DSS and how it could 
be achieved across settings.
 ► Potential challenges to using proposed solutions as 
well as ways to address these and ensure sustainability.
 ► Definitions of ‘success’ from various perspectives.
The interview guides were tailored to the roles and 
organisations of individuals. Each interview took between 
20 min and 1 hour. Interviews with policymakers explored 
strategic drivers for DSS and how these fit within the 
wider political and supplier landscape within NHS Scot-
land. Interviews with clinicians explored their attitudes 
towards the DSS Platform, how it could impact their work 
and how it could integrate with their existing practices.
During workshops, the researcher (MC) recorded the 
layout of the room, the actors and their roles, how the 
Platform was perceived to be received, emerging attitudes 
and reactions and the researcher’s own impressions/feel-
ings in relation to the observation.
With written consent from participants, interview data 
were digitally audio recorded and transcribed verbatim 
by a professional transcriber. The researchers (KC and 
MC) also recorded field notes for each meeting, interview 
and for observations.
data analysis
Our analysis was informed by the sociotechnical 
approach.16 20 This focuses on exploring structural 
technological factors and associated social processes as 
well as the inter-relationship between the two during 
implementation and optimisation. The sociotechnical 
approach has been applied widely to understand, for 
example, how technological change can result in changes 
to work practices of healthcare professionals, and vice 
versa, and how users can shape technological designs.
Data were thematically analysed, initially within stake-
holder groups in order to explore different viewpoints 
and then data sources were triangulated. We drew on 
our previous work in this area as a deductive coding 
framework, where possible. In addition, we inductively 
identified emerging themes.21 Themes were developed 
based on frequency of occurrence and salience among 
different stakeholder groups. Negative cases, that is, 
those that did not fit within the narrative, were explored, 
keeping potential implications for the national strategy in 
constant focus.
Findings across stakeholder groups were then 
compared in analysis meetings of the research team. This 
involved discussing commonalities and differences across 
data sources and participant groups, as well as exploring 
potential underlying explanations for differences and 
remaining tensions. Although we observed subtle differ-
ences across participant groups (which we explain in 
the Results section), our general findings were broadly 
comparable, so consensus was achieved though aggre-
gating findings at higher analytical levels.
reSultS
We conducted 30 one-to-one interviews and observed 
eight workshops between 10 May 2018 and 30 October 
2018. Participants are summarised in table 1.
We identified four key themes which we explore in 
detail with illustrative quotes:
 ► Widespread recognition of the potential value of DSS.
 ► Leadership and strategy to implement DSS nationally.
 ► The important role of usability and interoperability.
 ► Risk of unintended consequences emerging from 
implementation of DSS.
Widespread recognition of the potential value of dSS
All interviewees and workshop attendees agreed that, in 
line with existing empirical evidence, the strategic deci-
sion to implement DSS in NHS Scotland was the right way 
forward.
With good supportive decision-making, people have 
a better chance of getting the right care at the right 
time in the right place. Not the wrong care too 
late at excessive cost, with disabling consequences. 
(Participant 1, male, Policy)
Participants expected DSS to have a positive impact 
on safety, quality and efficiency. Areas and potential 
outcomes mentioned most frequently are summarised 
in table 2, although it is important to note that many of 
these related to the expected impact of digital health 
initiatives more generally rather than being associated 
with DSS. The only two areas that were specifically related 
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Table 1 High-level interview participants
Participant No Gender Background
1 Male Primary care policy
2 Female Social care policy
3 Male Patient
4 Male Performance and 
delivery policy
5 Female Prescribing policy
6 Male Public health policy
7 Female Planning and quality 
policy
8 Male GP
9 Male Developer
10 Female Social services policy
11 Female Public health policy
12 Female Nursing policy
13 Male Hospital doctor
14 Male Hospital doctor
15 Male Hospital doctor
16 Male GP
17 Female Pharmacist
18 Male GP
19 Female Pharmacist
20 Male GP
21 Male GP
22 Male Pharmacist
23 Male GP
24 Female Pharmacist
25 Male GP
26 Male GP
27 Female GP
28 Male GP
29 Female GP
30 Male Pharmacist
GP, general practitioner.
to DSS were adherence to guidelines and availability of 
information.
The expected areas of impact frequently aligned with 
important policy drivers around guideline implementa-
tion and person-centred approaches to decision-making 
in health and social care settings.22 23 For example, stake-
holders talked of giving patients more power to decide on 
their own treatment. A typical response was:
…I think hopefully it’s a better care for that patient 
and a more informed patient as well, so they know 
more about their treatment and why they’re on a 
treatment and therefore can help…making a deci-
sion in conjunction with the clinician. I think that’s 
going to be quite beneficial for patients as well to give 
them more empowerment… (Participant 22, male, 
Pharmacist)
However, the definition of outcome measures was 
perceived to be difficult and the long time to realise 
potential benefits was highlighted. Participants also 
acknowledged that outcomes would be dependent on the 
DSS application in question, and some interviewees were 
not entirely clear which application was included in the 
Platform.
I come across decision support in various different 
guises. Or for what I would consider decision sup-
port. (Participant 13, male, Clinical Lead)
Despite the overall positive attitudes among partici-
pants, we also observed concerns that expectations may 
not necessarily match system functionality. For example, 
many clinicians discussed a more general problem of 
information overload and the difficulty of navigating 
different sources of information. One GP stated that she 
often had open 10 tabs on her computer at a time, while 
another mentioned going in and out of different systems, 
and several stated carrying folders of paper-based records. 
Participants therefore highlighted evaluation of benefits 
as a priority area.
leadership and strategy to implement dSS nationally
While no participant expressed an overt negative opinion 
on the concept of DSS in principle, early and ongoing 
engagement with clinicians and other healthcare staff was 
viewed as crucial during system development and imple-
mentation. Participants were positive towards the concept 
of DSS, but had some concerns about how this would 
work in practice. At one workshop, a male GP emphasised 
that his comments should not be seen as negative but ‘in 
the spirit of improving the system’.
So their forward travel seems to be in the right direc-
tion providing that…the final product will work as it’s 
supposed to work…we’ve got 10 min. That has a big 
impact on your time whereas if you’ve got something 
popping up that can do these things then it should 
work far more efficiently. (Participant 20, female, GP, 
Tayside)
Participants wanted to get ‘hands-on’ experience of 
using the system and be engaged in ongoing develop-
ment to ensure that it worked in practice as well as in 
theory. Ongoing stakeholder engagement was also stated 
to be necessary to raise the profile of the Platform among 
the wider healthcare workforce.
The actual workshop…was a good step in the right 
direction, but I think for people who aren’t aware 
of these things, not just GPs but pharmacists, nurs-
ing and other kind of clinicians, I think a wee bit of 
work needs to be done to raise its profile. I really en-
joyed looking at the screens and saw great potential. 
(Participant 27, female, GP)
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Table 2 Expected areas of impact and potential outcomes of DSS
Expected area of impact Potential outcomes
Integration of care through securely shared digital 
information across primary, secondary and social 
care settings
Reduced duplicate data entry.
Patient satisfaction/feedback (by not being asked the same questions in 
a variety of settings, especially those with multiple chronic conditions).
Frequency of medication reviews at care transitions.
Medicines reconciliation between care settings.
Reduction in delayed discharge.
Improved data availability.
Adherence to guidelines (DSS specific) Reducing inappropriate variation of clinical practice.
Improved adoption of current evidence in clinical practice.
Patient self-management Adherence to treatment regimen.
Patient access to digital records and illness/wellness information.
Reduced travel for patients.
Reduced visits to primary care.
Improved patient quality of life.
Improved patient autonomy/confidence in managing chronic conditions.
Patient engagement and shared decision-making 
by supporting clinicians to explain choices of 
treatment and reasons for prescriptions (an effect of 
discussing choice so that the patient would be more 
engaged in decisions and would understand why 
decisions were taken)
Patient access to digital records, consultation information and digital 
information tailored to their needs.
Patient and carer involvement in determining their own needs and health 
outcomes.
Supported self-management for patients.
Improved patient confidence and literacy in discussing their care needs 
with clinicians and in making treatment choices.
Increased integration of health and social care.
Improved attitude among and training for clinicians towards shared 
decision-making.
Patient satisfaction.
Availability of appropriate information tailored to the 
needs of patients and clinicians (DSS specific)
Facilitating access to relevant information when it is needed.
Facilitating access to up-to-date evidence.
More efficient management of time for clinicians Less time spent manually searching through guidelines.
Shorter length of appointments.
Increased patient contact.
Shorter length of appointments.
Supporting changing roles within the multidisciplinary healthcare team, 
for example, facilitated delegation of patients with less complex needs to 
other practice staff (eg, pharmacists, nurse practitioners).
DSS, decision support systems.
We also observed a tension between a perceived lack 
of strong national-level leadership (which was considered 
to be needed for the successful implementation of the 
strategy) and staff changes within the eHealth Directo-
rate of the Scottish Government. Several interviewees 
stated that these changes caused challenges surrounding 
strategic priorities and direction of travel.
…my preference is…we have a sense of where we’re 
going to prioritise the initial investment and that is 
all coordinated from the one position, rather than 
from a variety of different piecemeal pockets and 
funded…it needs the central coordinating function. 
(Participant 13, male, Clinical Lead)
While calling for central leadership and direction, 
participants also acknowledged that a variety of different 
projects had to be managed under a portfolio-based 
approach. Here, there appeared to be a tension between 
the perceived need to have a firm direction of travel 
beyond Platform implementation and the multitude 
of ongoing DSS initiatives across settings (including 
primary, secondary and social care). While leadership was 
seen to be required to ensure alignment of initiatives and 
avoid silos, there was also a perceived need to recognise 
that strategy was sufficiently agile to cope with changing 
demands and stakeholder experiences.
I think [Platform] is one of the potential ways…the fact 
that there’s a number of pilots which have been started 
to test and to see what learning we can take from that, 
to me feels that the right approach. But it might not be 
the only approach…we have to make sure that we look 
slightly beyond that to say, okay, and this is what we’ve 
got, this is the tools that we have in the here and the 
now. But we know that the world is changing…as tech-
nology’s concerned it’s changing really, really quickly. 
So, we need to be preparing ourselves for that next 
leap, as well. (Participant 12, female, Policy)
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System usability and interoperability
The Digital Health and Care Strategy provided a mandate 
for integration of digital health systems in Scotland and the 
Platform (which adheres to OpenEHR and Fast Healthcare 
Interoperability Resources open standards) fits in well with 
this.23 24 However, it did at the time of our work not inte-
grate with Egton Medical Information Systems and Vision, 
primary care EHR systems procured centrally in Scotland. 
Participants expressed hope that this integration would 
be possible in the future. In the interim, developers had 
created interfaces that allowed interfacing with the Plat-
form but did not provide full integration.
I think it will have to [integrate], but how we get to 
that point, I'm not sure. So we do have a contractual 
requirement for [developers] to deliver, and interact 
with our clinical decision support systems. So any sup-
plier would, notionally, at least, have to be able to do 
that. (Participant 14, male, Clinical Lead)
What we do know is we are using a demonstrator envi-
ronment with the look and feel exactly like it will look 
in reality, but for the real integration we will most 
likely use a third-party developer in the first phase. 
(Participant 9, male, Developer)
System integration was also perceived to be crucial from 
a usability viewpoint and clinical interviewees expressed 
strong concerns that the Platform may not effectively inte-
grate with other primary and secondary care systems (as 
well as their existing in-built DSS). This lack of integra-
tion, it was feared, may lead to slowing down of existing 
systems and parallel data entry (leading to duplication of 
data entry and data inconsistency).
We feel like we’ve got lots of systems that work sepa-
rately. Now, they don’t talk to each other…so you end 
up having to put data into more than one system…so 
if they could talk to each other a bit better I think that 
would help. (Participant 25, male, Consultant)
Another perceived factor potentially affecting end-user 
usability was the degree of local customisation needed to 
tailor the number of pop-ups to local needs and avoid 
alert fatigue. Clinicians also mentioned that they were 
already presented with pop-ups in their own GP systems 
and that alerts from various sources needed to be aligned 
and thresholds for alerting set carefully in close consulta-
tion with them to ensure usability.
Pop-ups come up from all different places, so there’s 
the notes that practices put on the systems to try and 
remind you to do something…you’re potentially go-
ing to throw another set of pop-ups in there to have 
your clinical decision support… (Participant 21, 
male, GP)
risk of unintended consequences emerging from 
implementations of dSS
As clinicians had only seen pilot versions of the software 
in test environments and some had previous negative 
experiences of using new digital systems, there were 
uncertainties around the use of the Platform in real-
life settings. For example, clinicians mentioned the risk 
of duplication of work and increased workloads despite 
their desire for more time with patients.
… to introduce that amount of potentially new infor-
mation into a consultation that’s very, very tight time 
wise is always going to be a challenge. (Participant 21, 
male, GP, Glasgow)
It was also viewed as important to avoid over-reliance on 
systems by those with insufficient clinical experience and 
to ensure that the system did not attempt to replace the 
expertise of clinicians.
It’s useful to see amount of information available, 
but it could lead you down the wrong pathway and 
be in charge rather than the doctor. They [GPs] have 
the background knowledge of the patient and want 
to use their expertise. (Glasgow Workshop, Table 
Feedback)
Several stakeholders in the workshops and in interviews 
also highlighted some potential tensions between deci-
sions of clinicians and patients, with GPs generally being 
more risk averse than patients. Some therefore argued 
that DSS should be patient informed and not patient 
led, with the ultimate decision of treatment being in the 
hands of the clinician.
Patients take more risks than doctors but the clinician 
is responsible for them it should be patient-informed 
but not patient-led. (Participant 20, male, GP)
Another concern expressed at workshops and in inter-
views was that, for clinicians, the patient-centred approach 
may be in direct contrast to other policy drivers such as 
efficiency and patient outcomes. GPs described scenarios 
where patients might choose minimal intervention and 
therefore have a worse outcome.
You’re trying to reduce variability for drugs etc. but 
this can go against [patient centred approach] where 
you are giving personal choice. How can success be 
measured? (Glasgow Workshop, Table Feedback)
dISCuSSIon
Overall, we observed a strong sense of support from all 
stakeholders for the concept of DSS and, if it worked as 
they expected and through sustained end-user engage-
ment, associated plans to roll it out across NHS Scotland. 
As this was a first of type, and as the Platform, at the time 
of our evaluation, only existed in pilot settings, there were 
also some tensions. These included the need for strong 
national leadership and associated strategy allowing for 
a degree of local input, system usability associated with 
alert fatigue and integration with existing systems, and 
ongoing monitoring of potential benefits and unintended 
consequences emerging from implementations.
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Strengths and limitations
This evaluation offered important opportunities for 
realising true impact through ongoing formative feed-
back to policymakers. In doing so, our written progress 
reports have informed a business case submitted to Scot-
tish Government in October 2018 for further funding of 
the Platform beyond pilot sites. It also allowed to adjust 
to changing policy landscapes and emerging priori-
ties through the timely delivery of formative feedback 
and contributed to building clinical and policy-level 
engagement.
The formative real-time nature of this work has, however, 
also posed some challenges for all involved. Changes in 
policy priorities and emerging findings necessitated flex-
ible changes to our initially planned methodology over 
the course of our work in order to ensure that it remained 
relevant. For example, although we had initially planned 
to work with settings that had implemented systems as 
part of the Programme, only some functionality existed 
at the time we began our work. Such delays are common 
in large public initiatives. Interviews with policymakers 
further indicated a strong interest in the Platform, as a 
cloud-based CDS Platform based on open standards, 
which fits well with ongoing efforts to create a National 
Digital Platform that facilitates interoperability of health 
and care services.24
Moreover, our funders also acted as gatekeepers to 
participants and workshops. The sample may therefore 
not be representative of the wider stakeholder groups 
and reflecting the range of voices surrounding the DSS 
landscape. Participants consisted largely of those who 
were already engaged and might not reflect the views of 
wider stakeholders. As a result, our findings are likely to 
provide an incomplete picture of reality and should be 
interpreted with caution, despite (or precisely because 
of) fulfilling their purpose of delivering political impact. 
We have also not yet had sight of the business case, which 
our work has contributed to, so it difficult to position our 
work in the evolving policy landscape.
It is further important to recognise that this work pres-
ents only a snapshot of an early evaluation of the begin-
nings of a national programme. It by no means provides a 
complete picture and calls for more in-depth and longitu-
dinal work to assess ongoing developments and use over 
time.25 For example, it was in some instances not clear 
to us if clinicians and policymakers really understood the 
implications of using the Platform in the ‘real world’ as 
the workshop demonstrations were based on idealised 
scenarios. Real challenges may only emerge/materialise 
when the system is tested and a later stage in development 
and when it is used in practice.
Integration of findings with the current literature
Emerging issues in this work reflect tensions present in 
many large-scale digital change initiatives in healthcare 
settings. While the rationale for change and the value 
proposition of the Platform was clear to all participants 
in this work, the leadership and governance model going 
forward was an important concern. One common theme 
was the agreement that there needed to be a mixture 
between ‘bottom-up’ and ‘top-down’ approaches to 
implementation, ensuring a degree of central leadership 
and direction while also allowing for local input in deci-
sion-making.26 This balance is crucial, as many existing 
‘failed’ change initiatives such as the National Programme 
for Information Technology (NPfIT) have illustrated that 
national ‘top-down’ approaches alone are insufficient to 
realise the benefits associated with large-scale change in 
healthcare settings. In the NPfIT, ‘top-down’ strategies 
were superseded by locally driven strategies, and ulti-
mately changed to a more ‘middle-out’ model, where 
national strategic direction aligns more closely with local 
strategy.27
Both clinical and policy stakeholders in our sample 
had a strong desire for systems to save time and improve 
safety, quality and efficiency of care. However, as the 
expected areas of impact in table 2 illustrate, the impact 
of the DSS may be overestimated which may lead to prob-
lems and frustration during implementation. Similarly, 
time savings stand in stark contrast to the often long 
and painful implementation experiences in healthcare 
settings where benefits of digital systems can take a long 
time to materialise, and where benefits are often not 
visible to those who take the additional burden associ-
ated with their implementation.28 29 This long pathway 
to benefits is often due to social dimensions surrounding 
the technology, including, for example, adverse impacts 
on work practices and increased workloads, the poten-
tial introduction of new errors, adverse impacts on time 
spent with patients and unrealistic stakeholder attitudes/
expectations.30–32
While most participants were optimistic in relation 
to potential benefits of the Platform, there were also 
some major concerns. These related mainly to the 
would-be adopters interacting with technologies, and 
specifically usability and integration with existing work-
flows. Issues with system usability adversely affecting 
adoption patterns feature consistently in the empirical 
literature. In particular, the issue of alert fatigue in DSS 
and information overload among clinicians remains an 
unresolved area internationally.33–35 There is a trade-off 
between the number of alerts and the attention of 
clinicians, which has led some to advocate the use of a 
limited user-determined number of carefully designed 
pop-ups.36
An increasing number of interfaces can adversely 
affect system performance and usability and also lead 
to the introduction of new errors. Our work exploring 
the implementation of hospital electronic prescribing 
systems has shown that integration and interfacing prob-
lems could in some cases inhibit the effective transfer of 
information, leading to duplicate data entry and adverse 
effects on the availability of information.15 37 This high-
lights that therefore particular attention needs to be 
given to effective integration of the Platform with existing 
primary care systems.
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box 3 recommendations to tackle potential local and 
national tensions
 ► Developing a strategy allowing for a degree of local customisation of 
systems and managed tailoring of alerts. The devolving of respon-
sibility to local level needs to be tempered by the legal requirement 
to comply with the Medical Device Regulations for Decision Support 
that are classified as medical devices.
 ► Ongoing system development and optimisation with sustained 
stakeholder engagement including ‘hands-on’ experience for 
clinicians.
 ► Local organisations need to recognise the value of systems—a lim-
ited number of pilots that are carefully evaluated will help to engage 
other organisations yet to implement and will help to identify and 
mitigate emerging risks early.
 ► There is a need to develop a nuanced benefits realisation framework 
that combines smaller and locally relevant measures determined by 
implementing sites with national progress measures.
Policy recommendations and implications for practice 
emerging from this work
Recognising the early stages of this evaluation, our work has 
some preliminary implications for policy to ensure long-
term sustainable delivery of the Platform. Most importantly, 
sufficient time and resources need to be available to imple-
ment, facilitated by overall national ownership to support 
the implementation of the Platform within the eHealth 
Directorate. This work also needs to align with the devel-
opment of the wider National Digital Platform (which is 
planned to connect all digital health and care services in 
Scotland) to facilitate interoperability and the wider Scot-
tish Digital Health and Care Strategy to facilitate alignment 
with national strategic priorities.23 24
As technology landscapes and needs are constantly 
changing, future iterations of the Programme have to 
be sufficiently agile. Revisiting the original document at 
predefined time points informed by ongoing evaluation 
and stakeholder engagement is likely to facilitate these 
developments. This should also involve ongoing commu-
nications about the current strategy and associated times-
cales, stakeholder engagement opportunities and resulting 
actions, as well as ‘hands-on’ experience of system use.
In order to promote usability, there is a need to negotiate 
seamless integration with existing primary care systems, 
as interfaces as interim solutions can adversely affect user 
experiences. The negotiation with primary care system 
suppliers and promoting seamless integration through 
effective user interfaces is therefore key going forward.
There are further a number of potential ways to tackle 
tensions between local and national dynamics. These are 
summarised in box 3.
As this evaluation has focused on the very early stages of 
piloting, our findings are preliminary. We strongly recom-
mend ongoing formative evaluation of the implementa-
tion of the Platform through longitudinal work to ensure 
effective alignment with wider strategy, and continuous 
stakeholder engagement. This work needs to include a 
designated strand exploring evolving policy and supplier 
landscapes and market management.
ConCluSIonS
Our work has laid the early foundations for a formative 
longitudinal evaluation of the DSS Programme in Scotland. 
It has helped to promote early engagement of key stake-
holders and also informed policy planning by identifying 
key clinical and political drivers of system implementa-
tion, and challenges that are likely to warrant negotiation 
going forward. These include achieving a balance between 
national targets and local incentives, system usability and 
benefits realisation. Careful ongoing formative evaluation 
guided by the evaluation framework developed as part of 
this work will help systems to realise their maximum poten-
tial while minimising disruption to existing services.
Our formative methods have the potential for imme-
diate impact on practice and we believe that interna-
tional settings can learn from these early insights. We 
have shown that a relatively modest evaluation budget 
can help to actively shape strategic developments by high-
lighting challenges, identifying potential pain points and 
informing proactive decision-making that is likely to avoid 
many of the obstacles faced by digitally enabled change 
projects. Formative evaluation activities can therefore 
provide significant value as they help to gain insights into 
local challenges through contextualising wider empirical 
findings. Applying empirical insights without analysing 
local dynamics is likely to be of limited value.
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